{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-050488","form_type":"8-K","ticker":"ICCC","cik":"0000811641","company_name":"IMMUCELL CORP /DE/","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.329879+00:00","generated_at":"2026-06-13T20:24:49.280574+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ImmuCell appoints Bryan Gathagan to board; board extends rights plan despite advisory vote failure","bullets":["Bryan K. Gathagan appointed independent director effective June 16, 2023; appointed to Audit Committee.","Non-binding advisory vote on extending rights plan by one year failed with 42% of shares present, but 65% of votes cast in favor.","Board extended Common Stock Rights Plan to September 19, 2024 despite advisory vote failure.","All six director nominees elected; Wipfli LLP ratified as auditor for FY2023.","5.7M shares represented (73% of outstanding) at annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-050488","json":"https://secwatch.observer/filing/0001213900-23-050488.json","markdown":"https://secwatch.observer/filing/0001213900-23-050488.md","text":"https://secwatch.observer/filing/0001213900-23-050488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/ea180740-8k_immucell.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:24:49.280574+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f97903625","claim":"Bryan K. Gathagan was elected as independent director at IMMUCELL CORP /DE/.","evidence_excerpt":"Pursuant to a recommendation by the Nominating Committee, the board of directors (the “Board”) of ImmuCell Corporation (the “Company”) elected Mr. Bryan K. Gathagan as an independent director, effective June 16, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"},{"claim_id":"028a9e449c7b5331523a2c07c0d73938fd2e5145","claim":"IMMUCELL CORP /DE/ shareholders approved To approve a non-binding advisory resolution on the Company’s executive compensation program. at the 2023-06-15 meeting.","evidence_excerpt":"2. To approve a non-binding advisory resolution on the Company’s executive compensation program: For Against Abstain Broker Non-votes 3,293,046 76,241 303,370 2,032,888","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"bc8929ad824ad8713afd963f88d06654ad783493","claim":"IMMUCELL CORP /DE/ shareholders approved To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2023. at the 2023-06-15 meeting.","evidence_excerpt":"4. To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2023: For Against Abstain Broker Non-votes 5,687,633 9,343 8,569 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"e4163641010031dbc81292ace4e821dd3de96a2a","claim":"IMMUCELL CORP /DE/ shareholders approved To elect to one-year terms as Directors of the Company the six nominees listed in the 2023 Proxy Statement. at the 2023-06-15 meeting.","evidence_excerpt":"1. To elect to one-year terms as Directors of the Company the nominees listed in the Company’s Proxy Statement dated April 28, 2023: For Withheld Broker Non-votes Gloria J. Basse 3,594,248 78,409 2,032,888 Michael F. Brigham 3,590,547 82,110 2,032,888 Bobbi Jo Brockmann 3,614,602 58,055 2,032,888 Steven T. Rosgen 3,592,944 79,713 2,032,888 David S. Tomsche 3,555,331 117,326 2,032,888 Paul R. Wainman 3,547,166 125,491 2,032,888","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"f5a0b16dbbbd1abd9e3c850526bb2ab8c091acd3","claim":"IMMUCELL CORP /DE/ shareholders rejected To approve a non-binding advisory vote on whether to amend the Company’s Common Stock Rights Plan extending its expiration date by one year to September 19, 2024. at the 2023-06-15 meeting.","evidence_excerpt":"3. To approve a non-binding advisory vote on whether to amend the Company’s Common Stock Rights Plan extending its expiration by one year to September 19, 2024: For Against Abstain Broker Non-votes 2,390,931 1,270,796 10,930 2,032,888","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390023050488/0001213900-23-050488-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}